Skip to content

effect of eptifibatide and reteplase on primary angioplasty outcomes

Comparison of the efficacy of intracoronary and intravenous Eptifibatide and intracoronary Retaplase on coronary blood flow in patients undergoing PPCI at Dr.Heshmat hospital during 2017-2018 (Randomized clinical trial study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170925036401N1
Enrollment
160
Registered
2017-12-07
Start date
2017-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction. Acute myocardial infarction

Interventions

Intervention 1: Intervention group: Group 1: Patients who have a stent after thrombosuction. Intervention 2: Intervention group:Group 2: Patients who receive 180 microgram per kilogram of intracoronar
Treatment - Drugs
Intervention group: Group 1: Patients who have a stent after thrombosuction.
Intervention group:Group 2: Patients who receive 180 microgram per kilogram of intracoronary bolus eptifibatide by interval of 10 minutes and then stent is embeded.
Intervention group:Group 3: Patients who receive 6 mg of intra-coronary reptal after thrombosis, and then inserted into the stent.
Intervention group: Group 4:Patients after thrombosuction will receive 180 microgram per kilogram of intravenous bolus eptifibatide and then receive 2 microgram per kilogram per minute of infusion ove

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ischemic tipic chest pain extending more than 30 min, STelevation more than 1 mm in at least 2 leads with the same name, all patients with STEMI candidate for primary PCI, myocardial infarction not extending more than 12 hours, having life expectancy not less than 6 months, consent for participation in the study, age 18 to 80 years, no evidence for prior myocardial infarction, not having contraindications for reteplase or eptifibatide, not having left bundle branch block, not using GPIIb/IIIa in recent two weeks.

Exclusion criteria

Exclusion criteria: rescue PCI after thrombolytic therapy, emergency CABG, cardiogenic shock, atrial fibrillation TIMI flow grade 3 in primary angiography(ie, having normal blood flow in coronary arteries) simultaneously presence in another intervention study

Design outcomes

Secondary

MeasureTime frame
Left ventricular diastolic dysfunction change. Timepoint: before and after angiography. Method of measurement: according to echocardiographic criteria.;ST resolution average. Timepoint: before and 90 minutes after PCI. Method of measurement: based on electrocardiogram.;Average of EF changes. Timepoint: before and 3 to 4 days after angioplasty. Method of measurement: based on echocardiography.

Primary

MeasureTime frame
Coronary blood flow. Timepoint: before and after primary PCI. Method of measurement: based on angiographic scale TIMI blush grade.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMostafa Zadkamali

Rasht University of Medical Sciences

mzadkamali@gums.ac.ir+98 13 3333 6394

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026